Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises HMS Networks AB in connection with the admission to the OMX Nordic Stock Exchange in Stockholm
Mandate

Vinge advises HMS Networks AB in connection with the admission to the OMX Nordic Stock Exchange in Stockholm

October 19, 2007

Vinge is the legal advisers of HMS Networks AB in connection with the admission to the stock exchange. The offer comprises 6,491,050 shares, representing 61.4 per cent of the shares and the votes in the company, and will be carried out through the sale of shares by Segulah II L.P., Nicolas Hassbjer (directly and through companies) and Staffan Dahlström (directly and through companies). Subject to complete acceptance of the offer and the over-allotment option being exercised in full, the total value of the offer will amount to MSEK 464 – 571 which corresponds to a value of outstanding shares in the company of MSEK 687 – 846.

Göran Nyström is the partner responsible assisted by associates Jesper Schönbeck, Christine Andersen, Petter Elmstedt and Emil Hedberg.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026